| Literature DB >> 32638947 |
Daniela Brianne Martins Dos Anjos1, Adriana Safioti Toledo Ricardi1, Carla Fernanda Borrasca Fernandes1, Camila Carbone Prado1, Eduardo Mello De Capitani1, Fábio Bucaretchi1.
Abstract
OBJECTIVE: To describe a case series of severe acute toxic exposures (SATE) in individuals <20 years old followed-up by a regional Poison Control Center (PCC).Entities:
Mesh:
Year: 2020 PMID: 32638947 PMCID: PMC7333941 DOI: 10.1590/1984-0462/2021/39/2019262
Source DB: PubMed Journal: Rev Paul Pediatr ISSN: 0103-0582
Final classification of toxic exposure cases followed by the Campinas Poison Control Center (PCC) (2014 and 2015), in children and adolescents, according to the outcome and age group (years old).
| Outcome (PSS)/age group (years old) | <1 | 1-4 | 5-9 | 10-14 | 15-19 | Total | % |
|---|---|---|---|---|---|---|---|
| Asymptomatic (PSS=0) | 250 | 2,027 | 346 | 212 | 273 | 3,108 | 61.0 |
| Mild (PSS=1) | 86 | 675 | 241 | 208 | 301 | 1,511 | 29.7 |
| Moderate (PSS=2) | 22 | 76 | 40 | 37 | 46 | 221 | 4.3 |
| Severe (PSS=3) | 1 | 4 | 2 | 2 | 15 | 24 | 0.5 |
| Fatal with causal nexus (PSS=4) | 0 | 2 | 2 | 0 | 2 | 6 | 0.1 |
| Potentially toxic exposures without monitoring | 3 | 10 | 1 | 1 | 1 | 16 | 0.3 |
| Death from another cause | 3 | 2 | 1 | 1 | 0 | 7 | 0.1 |
| Ignored | 14 | 98 | 26 | 27 | 37 | 202 | 4.0 |
| Total (%) | 379 (7.4) | 2,894 (56.8) | 659 (12.9) | 488 (9.6) | 675 (13.2) | 5,095 (100) | 100 |
PSS: poisoning severity score.
Cases of severe acute toxic exposures in children and adolescents according to age group (years old) in relation to the circumstance of exposure, group of agents and evolution.
| Age group (years old) | <1 | 1-4 | 5-9 | 10-14 | 15-19 | Total |
|---|---|---|---|---|---|---|
| Circumstance of exposure | ||||||
| Accidental | 1 | 6 | 3 | 2 | 3 | 15 |
| Intentional | 0 | 0 | 0 | 0 | 14 | 14 |
| Not clarified | 0 | 0 | 1 | 0 | 0 | 1 |
| Group of agents | ||||||
| Venomous animals | 0 | 0 | 3 | 2 | 3 | 8 |
| Medications | 1 | 0 | 1 | 0 | 6 | 8 |
| Household or industrial chemicals | 0 | 5 | 0 | 0 | 1 | 6 |
| Rodenticides for illegal use
( | 0 | 0 | 0 | 0 | 4 | 4 |
| Drugs of abuse | 0 | 0 | 0 | 0 | 3 | 3 |
| Button battery | 0 | 1 | 0 | 0 | 0 | 1 |
| Evolution | ||||||
| Cure | 1 | 2 | 2 | 2 | 14 | 21 |
| Anatomical sequelae (caustic esophageal stenosis) | 0 | 2 | 0 | 0 | 1 | 3 |
| Fatal | 0 | 2 | 2 | 0 | 2 | 6 |
Cases of severe acute toxic exposures in children and adolescents according to the agents involved and the evolution (sequelae and deaths).
| Agents involved, including associations | N | Sequelae | Deaths |
|---|---|---|---|
| Venomous animals | |||
| Scorpions | |||
| Unidentified species (possibly | 4 | 0 | 0 |
|
| 1 | 0 | 1 |
| Unidentified rattlesnake (possibly | 3 | 0 | 0 |
| Medications | |||
| Brimonidine | 1 | 0 | 0 |
| Carbamazepine | 1 | 0 | 0 |
| Carbamazepine and diazepam | 1 | 0 | 0 |
| Captopril and sertraline | 1 | 0 | 0 |
| Amitriptyline, diazepam and paracetamol | 1 | 0 | 0 |
| Valproic acid, haloperidol and promethazine | 1 | 0 | 1 |
| Chlordiazepoxide, lamotrigine, sertraline, venlafaxine and desogestrel | 1 | 0 | 0 |
| Carbamazepine, lithium carbonate, chlorpromazine, diazepam, phenytoin and phenobarbital | 1 | 0 | 0 |
| Household or industrial chemicals | |||
| Corrosive | |||
| Sodium hydroxide | 2 | 2 | 0 |
| Sodium dodecylbenzenesulfonate | 1 | 0 | 1 |
| Chlorine for swimming pool | 1 | 1 | 0 |
| Kerosene | 1 | 0 | 0 |
| Hydrocarbon solvent (derivatives of N-hexane)* | 1 | 0 | 1 |
| Rodenticides of clandestine use (chumbinho) | |||
| Cholinesterase inhibitors ** | 4 | 0 | 1 |
| Drugs of abuse | |||
| Cocaine and tetrahydrocannabinol | 1 | 0 | 1 |
| Phenylethylamine (NBOMe) | 1 | 0 | 0 |
| Inhalants† | 1 | 0 | 0 |
| Button battery | 1 | 0 | 0 |
| Total | 30 | 3 | 6 |
*The product accidentally ingested/inhaled was a pyrethroid insecticide, but the death resulted from exposure to the solvent present in the product (see case 1 synopsis); **not investigated by laboratory analysis if the cholinesterase inhibitor was a carbamate or an organophosphate; † presence of benzene and cyclohexane confirmed in the blood sample and chloroform in the urine sample.
Main clinical findings observed during admission and evolution of the 30 cases of severe acute toxic exposures, including syndromic diagnoses and treatments employed.
| Clinical, laboratory findings and treatments employed | n |
|---|---|
| Neuromuscular changes | |
| Neurological depression | 13 |
| Cholinergic syndrome | 4 |
| Myasthenic syndrome | 3 |
| Seizures | 3 |
| Severe rhabdomyolysis (total CK>10,000 U/L) | 3 |
| Psychomotor agitation | 2 |
| Serotonin syndrome | 1 |
| Cardiovascular changes | |
| Hypotension/shock | 12 |
| Myocardial injury (increase in serum CKMB and troponin) | 6 |
| Corrected QT interval widening (>440 ms) | 4 |
| Changes in the ST segment (depression and/or elevation) | 4 |
| Myocardial dysfunction (LV ejection fraction <56%) | 3 |
| Respiratory changes | |
| Respiratory failure | 11 |
| Pneumonia | 8 |
| Acute pulmonary edema | 4 |
| Others | |
| Acute kidney injury | 4 |
| Severe esophageal injury | 4 |
| Coagulopathy | 2 |
| Treatments used | |
| Parenteral hydration | 22 |
| Mechanical ventilation | 22 |
| Vasopressors / inotropes | 12 |
| Continuous atropine infusion | 4 |
| Anti-scorpionic antivenom | 4 |
| Anticrotalic antivenom | 3 |
| Renal replacement therapy | 3 |
| Multiple doses of activated charcoal | 3 |
| Prolonged parenteral nutrition | 2 |
| Intravenous N-acetylcysteine | 1 |
CK: creatine kinase; LV: left ventricle.